DK358875A - - Google Patents

Info

Publication number
DK358875A
DK358875A DK358875A DK358875A DK358875A DK 358875 A DK358875 A DK 358875A DK 358875 A DK358875 A DK 358875A DK 358875 A DK358875 A DK 358875A DK 358875 A DK358875 A DK 358875A
Authority
DK
Denmark
Application number
DK358875A
Other languages
Danish (da)
Other versions
DK139101B (da
DK139101C (cg-RX-API-DMAC7.html
Inventor
C Casagrande
G Ferrari
Original Assignee
Siphar S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Siphar S A filed Critical Siphar S A
Publication of DK358875A publication Critical patent/DK358875A/da
Publication of DK139101B publication Critical patent/DK139101B/da
Application granted granted Critical
Publication of DK139101C publication Critical patent/DK139101C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK358875AA 1974-08-08 1975-08-07 Analogifremgangsmåde til fremstilling af 3beta,14beta-dihydroxy-17beta-(4-pyridazinyl)-5beta-androstan-forbindelser. DK139101B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1085574A CH621803A5 (cg-RX-API-DMAC7.html) 1974-08-08 1974-08-08

Publications (3)

Publication Number Publication Date
DK358875A true DK358875A (cg-RX-API-DMAC7.html) 1976-02-09
DK139101B DK139101B (da) 1978-12-18
DK139101C DK139101C (cg-RX-API-DMAC7.html) 1979-05-21

Family

ID=4367535

Family Applications (1)

Application Number Title Priority Date Filing Date
DK358875AA DK139101B (da) 1974-08-08 1975-08-07 Analogifremgangsmåde til fremstilling af 3beta,14beta-dihydroxy-17beta-(4-pyridazinyl)-5beta-androstan-forbindelser.

Country Status (12)

Country Link
US (1) US4000125A (cg-RX-API-DMAC7.html)
JP (1) JPS5141372A (cg-RX-API-DMAC7.html)
AR (1) AR217617A1 (cg-RX-API-DMAC7.html)
BE (1) BE832271A (cg-RX-API-DMAC7.html)
CA (1) CA1049499A (cg-RX-API-DMAC7.html)
CH (1) CH621803A5 (cg-RX-API-DMAC7.html)
DE (1) DE2534981A1 (cg-RX-API-DMAC7.html)
DK (1) DK139101B (cg-RX-API-DMAC7.html)
ES (1) ES440110A1 (cg-RX-API-DMAC7.html)
FR (1) FR2281124A1 (cg-RX-API-DMAC7.html)
GB (1) GB1484655A (cg-RX-API-DMAC7.html)
SE (1) SE418401B (cg-RX-API-DMAC7.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1144136B (it) * 1980-03-05 1986-10-29 Zenyaku Kogyo Kk Glucosidi di condurango agenti antitumorali che li comprendono e procedimento per la loro preparazione
US5373095A (en) * 1985-10-18 1994-12-13 The Upjohn Company Steroid compounds
IT1262931B (it) * 1992-01-16 1996-07-22 Zambon Spa Composti steroidei 17(piridazin-n-ossido)-sostituiti attivi sul sistema cardiovascolare
DE4227616C2 (de) * 1992-08-20 1995-04-13 Sigma Tau Ind Farmaceuti 17-(3-Furyl)-und 17-(4-Pyridazinyl)-5beta, 14beta-androstanderivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammemsetzungen
JP5130453B2 (ja) * 2005-03-02 2013-01-30 ユニバーシティ オブ メリーランド,ボルティモア 新規なc−17−ヘテロアリールステロイドcyp17阻害剤/抗アンドロゲン:合成、インビトロ生物活性、薬物動態および抗腫瘍活性
GB2470873A (en) * 2008-03-12 2010-12-08 Univ Maryland Androgen receptor inactivation contributes to antitumor efficacy of CYP17 inhibitors in prostrate cancer
US20100048524A1 (en) * 2008-03-14 2010-02-25 Angela Brodie Novel C-17-Heteroaryl Steroidal CYP17 Inhibitors/Antiandrogens;Synthesis In Vitro Biological Activities, Pharmacokinetics and Antitumor Activity
WO2009120565A2 (en) 2008-03-25 2009-10-01 University Of Maryland, Baltimore Novel prodrugs of c-17-heteroaryl steroidal cyp17 inhibitors/antiandrogens: synthesis, in vitro biological activities, pharmacokinetics and antitumor activity
WO2009129208A2 (en) * 2008-04-14 2009-10-22 University Of Maryland, Baltimore Compositions and methods of inducing endoplasmic reticulum stress reponse
EP2393827B1 (en) 2009-02-05 2015-10-07 Tokai Pharmaceuticals, Inc. Novel prodrugs of steroidal cyp17 inhibitors/antiandrogens
GB2479693B (en) 2009-02-05 2014-04-09 Tokai Pharmaceuticals Inc Steroidal CYP17 inhibitors and their use in the treatment of cancer and prostate hyperplasia
EP2461814A4 (en) * 2009-08-07 2012-12-05 Tokai Pharmaceuticals Inc PROSTATE CANCER TREATMENT
CA2904170A1 (en) 2013-03-14 2014-09-25 University Of Maryland, Baltimore Androgen receptor down-regulating agents and uses thereof
KR20160058774A (ko) 2013-08-12 2016-05-25 토카이 파마슈티컬, 아이엔씨. 안드로겐-표적 치료제를 이용하는 종양 질환 치료를 위한 바이오마커
WO2017001204A1 (en) * 2015-06-29 2017-01-05 Universiteit Gent Methods for the site-selective coupling of a first agent to a second agent

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3838163A (en) * 1968-11-22 1974-09-24 Hoffmann La Roche Substituted isoxazole derivatives as steroid intermediates

Also Published As

Publication number Publication date
ES440110A1 (es) 1977-02-16
DE2534981A1 (de) 1976-02-19
FR2281124A1 (fr) 1976-03-05
CH621803A5 (cg-RX-API-DMAC7.html) 1981-02-27
SE7508908L (sv) 1976-02-09
DK139101B (da) 1978-12-18
US4000125A (en) 1976-12-28
FR2281124B1 (cg-RX-API-DMAC7.html) 1980-05-16
AR217617A1 (es) 1980-04-15
JPS5141372A (cg-RX-API-DMAC7.html) 1976-04-07
DK139101C (cg-RX-API-DMAC7.html) 1979-05-21
CA1049499A (en) 1979-02-27
GB1484655A (en) 1977-09-01
BE832271A (fr) 1975-12-01
SE418401B (sv) 1981-05-25

Similar Documents

Publication Publication Date Title
DK139101C (cg-RX-API-DMAC7.html)
DE2413037C3 (cg-RX-API-DMAC7.html)
DK131675A (cg-RX-API-DMAC7.html)
CS170633B1 (cg-RX-API-DMAC7.html)
CS167761B1 (cg-RX-API-DMAC7.html)
CS175796B1 (cg-RX-API-DMAC7.html)
CS169587B1 (cg-RX-API-DMAC7.html)
FI191174A7 (cg-RX-API-DMAC7.html)
CS177564B1 (cg-RX-API-DMAC7.html)
CS169494B1 (cg-RX-API-DMAC7.html)
CS162514B1 (cg-RX-API-DMAC7.html)
FI740019A0 (cg-RX-API-DMAC7.html)
CH594147A5 (cg-RX-API-DMAC7.html)
DD115539A1 (cg-RX-API-DMAC7.html)
CH589328A5 (cg-RX-API-DMAC7.html)
CH579472A5 (cg-RX-API-DMAC7.html)
CH583640A5 (cg-RX-API-DMAC7.html)
DD115966A1 (cg-RX-API-DMAC7.html)
CH618059B (cg-RX-API-DMAC7.html)
DD118429A5 (cg-RX-API-DMAC7.html)
DD121466A3 (cg-RX-API-DMAC7.html)
DD121890A5 (cg-RX-API-DMAC7.html)
CH600855A5 (cg-RX-API-DMAC7.html)
CH588991A5 (cg-RX-API-DMAC7.html)
CH592394A5 (cg-RX-API-DMAC7.html)